Nicholas Butowski, MD

Neuro-oncologist

Dr. Nicholas Butowski is a neuro-oncologist who specializes in brain tumors, neuro-imaging, cognitive and rehabilitative neurology and complementary therapy. He is director of clinical services in Neuro-oncology and a researcher in the Brain Tumor Research Center.

In his research, he focuses on the development of treatments for primary brain tumors as well as methods to ensure good quality of life for patients and methods to assist them in recovering from or coping with brain injury. Butowski earned a medical degree at the University of Illinois in Chicago, and completed a residency in neurology and a fellowship in neuro-oncology at UCSF. He is a member of the American Academy of Neurology, American Society of Clinical Oncology, International Society of Neuro-oncology and Society for Neuro-oncology. He is a professor of neurological surgery at UCSF.

Clinics

Brain Tumor Center
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2966
Fax: (415) 353-2167

Hours: Monday to Friday, 8 a.m. - 5 p.m.

Conditions & Treatments

Academic Title

Professor

More about Nicholas Butowski

Education

University of Illinois College of Medicine 1999

Residencies

UCSF Medical Center, Neurology 2003

Fellowships

UCSF Medical Center, Neuro-oncology 2004

Selected Research and Publications

  1. Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, Alexander BM, Colen R, Taylor JW, Arrillaga-Romany I, Mehta A, Huang RY, Pope WB, Reardon D, Batchelor T, Prados M, Galanis E, Wen PY, Cloughesy TF. Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro Oncol. 2018 Apr 05.
  2. Goode B, Mondal G, Hyun M, Ruiz DG, Lin YH, Van Ziffle J, Joseph NM, Onodera C, Talevich E, Grenert JP, Hewedi IH, Snuderl M, Brat DJ, Kleinschmidt-DeMasters BK, Rodriguez FJ, Louis DN, Yong WH, Lopes MB, Rosenblum MK, Butowski N, Tihan T, Bollen AW, Phillips JJ, Wiita AP, Yeh I, Jacobson MP, Bastian BC, Perry A, Solomon DA. A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle. Nat Commun. 2018 02 23; 9(1):810.
  3. Villanueva-Meyer JE, Wood MD, Choi BS, Mabray MC, Butowski NA, Tihan T, Cha S. MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis. AJR Am J Roentgenol. 2018 Mar; 210(3):621-628.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.